Hypereosinophilic Syndrome - 14 Studies Found

Completed : 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)
: Leukemia
: 2007-06-05
:
  • Drug: 2-CdA 12 mg/m^2/day by v
Completed : Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
:
  • Chronic Myelomonocytic Leukemia
  • Chronic Myeloid Leukemia
  • P
    : 2002-06-04
    : Drug: Imatinib Mesylate (Gleevec) Imatinib mesylate 400 mg orally daily, and in HES patients start with
Completed : Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
:
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Agnogenic
    : 2005-11-16
    : Drug: Dasatinib (BMS-354825) 70 mg orally twice daily
Completed : A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
:
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
    : 2005-05-02
    : Drug: Nilotinib
<<< Previous